Aging and the Kidney
Possible Mechanisms, Consequences, and Management Strategies
-
10% KEDVEZMÉNY?
- A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
- Kiadói listaár EUR 162.99
-
67 600 Ft (64 381 Ft + 5% áfa)
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.
- Kedvezmény(ek) 10% (cc. 6 760 Ft off)
- Kedvezményes ár 60 840 Ft (57 943 Ft + 5% áfa)
Iratkozzon fel most és részesüljön kedvezőbb árainkból!
Feliratkozom
67 600 Ft
Beszerezhetőség
Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
Why don't you give exact delivery time?
A beszerzés időigényét az eddigi tapasztalatokra alapozva adjuk meg. Azért becsült, mert a terméket külföldről hozzuk be, így a kiadó kiszolgálásának pillanatnyi gyorsaságától is függ. A megadottnál gyorsabb és lassabb szállítás is elképzelhető, de mindent megteszünk, hogy Ön a lehető leghamarabb jusson hozzá a termékhez.
A termék adatai:
- Kiadó Elsevier Science
- Megjelenés dátuma 2026. július 1.
- ISBN 9780443340697
- Kötéstípus Puhakötés
- Terjedelem450 oldal
- Méret 235x191 mm
- Nyelv angol 700
Kategóriák
Hosszú leírás:
Aging and the Kidney: Possible Mechanisms, Consequences, and Management Strategies explores the connection between kidney health and overall well-being with increasing age and longevity. The kidney contains both regenerative and terminally differentiated cells, serving as a crossroad for vascular and inflammatory processes, and regulates many conditions associated with chronic, progressive, and debilitating disease. Efforts to slow the decline in kidney function can enhance quality of life in the aging population. This book is organized into three main parts: mechanisms of the aging kidney, clinical consequences, and management and prevention. The first part examines histological, structural, physiological, and functional changes that contribute to age-related declines in kidney function. The role of nutrition and proteomics is also discussed.
The second part examines the functional decline in elderly patients and includes subparts on impaired quality of life, sleep quality, fall risk, frailty, depression, and sarcopenia. It also considers unique features of hypertension, diabetes, glomerulonephritis, and peripheral vascular disease. The final part focuses on diagnostic, management, and prevention strategies. The common myths about chronic kidney disease in the elderly are addressed, with particular attention to how a solitary kidney in living donors ages over time. Kidney function and its relationship to neurologic complications, cancers, and cardiovascular disease are explained, along with current treatment approaches, medications, and future directions in the care of elderly patients. This comprehensive work serves as a valuable resource for understanding how aging affects systemic health and offers potential pathways to enhance lifespan and well-being in elderly patients.
Tartalomjegyzék:
PART 1 - Mechanisms of aging in the kidney
1. Structure and physiological changes in the aging kidney
2. Models of aging kidney
3. Molecular mechanisms of aging in the kidney
4. The podocyte
5. Epigenetics and the kidney
6. The influence of acute kidney injury on aging
7. Nutritional considerations and aging
8. Proteomics in the kidney
PART 2 - Clinical Consequences
9. Functional impairment in elderly CKD patients
10. Unique characteristics of kidney diseases in the elderly
PART 3 - Management and Prevention
11. How to make a diagnosis of CKD in an elderly individual, since a decline in GFR is expected with normal healthy aging
12. Myths about CKD in the elderly
13. The living donor and aging
14. CNS limitations in the elderly kidney patient
15. Cancer and the kidney in an elderly individual
16. CKD and cardiovascular diseases (CVD) in an elderly individual
17. Benefits of RAAS blockage
18. Newer drugs and CKD
19. Drugs to avoid with geriatric kidney disease
20. Conservative management of ESRD